# CYTEIR THERAPEUTICS INC (CYTT)

> Institutional ownership reported to the SEC as of Q1 2024, from Form 13F filings. Source: https://holderbook.com/stocks/CYTT/

- Reporting holders: 4
- Reported value: $11.2M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [BML Capital Management, LLC](https://holderbook.com/funds/1616824-bml-capital-management-llc/) | $11.0M | 3,654,053 | 7.3% | 5 |
| [ACADIAN ASSET MANAGEMENT LLC](https://holderbook.com/funds/916542-acadian-asset-management-llc/) | $77.0K | 26,319 | 0.0% | 1 |
| [BOSTON FAMILY OFFICE LLC](https://holderbook.com/funds/1039807-boston-family-office-llc/) | $73.0K | 24,197 | 0.0% | 4 |
| [Lindbrook Capital, LLC](https://holderbook.com/funds/1767045-lindbrook-capital-llc/) | $6.0K | 2,006 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2024 | 4 | $11.2M |
| Q4 2023 | 38 | $38.9M |
| Q3 2023 | 41 | $46.3M |
| Q2 2023 | 39 | $41.7M |
| Q1 2023 | 30 | $28.0M |
| Q4 2022 | 29 | $28.5M |
| Q3 2022 | 35 | $34.6M |
| Q2 2022 | 38 | $56.8M |
| Q1 2022 | 50 | $83.8M |
| Q4 2021 | 48 | $253.4M |
| Q3 2021 | 38 | $344.1M |
| Q2 2021 | 32 | $352.6M |